A new drug developed by QIMR Berghofer could transform the treatment of COVID-19 by potentially protecting against infection by any SARS-CoV-2 variant and reversing the persistent inflammation that is a major driver of debilitating long COVID.

  • floofloof@lemmy.ca
    link
    fedilink
    English
    arrow-up
    2
    ·
    1 year ago

    Notice the credit for this article at the bottom:

    Provided by QIMR Berghofer

    So this really seems to be a press release from the company, not an independently written article.